2003
Company Outlines Progress Toward Drug Eluting Stent Milestones; Third Quarter and Full-Year 2003 Financial Guidance Affirmed Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...
Additional Equity Investment Strengthens Guidant''s Commitment to the Development of Future Technologies for Heart Surgery Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an update on the...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a third...
Latest Addition to Pacemaker Portfolio Offers Improved Therapy Options While Maintaining Size and Longevity Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...